# Dianthus Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Sep 15, 2025

- Company: [Dianthus Therapeutics, Inc.](/companies/dnth.md) (CIK 1690585)
- Form: SCHEDULE 13D/A
- Filed: 2025-09-15
- Accepted by EDGAR: Sep 15, 2025, 16:15 ET
- Period: not reported
- Accession: 0001104659-25-090015
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1690585/000110465925090015/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1690585/000110465925090015/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1690585/000110465925090015/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Sep 15, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-090015. Last ingested by Listed: Nov 13, 2026, 16:49 ET. No prices; not investment advice.
